J Neurol Surg B Skull Base 2019; 80(S 01): S1-S244
DOI: 10.1055/s-0039-1679733
Poster Presentations
Georg Thieme Verlag KG Stuttgart · New York

Incidence, Risk Factors, and Outcomes of Endoscopic Sinus Surgery after Endoscopic Skull Base Surgery

Ravi R. Shah
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Ivy W. Maina
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Neil N. Patel
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Vasiliki Triantafillou
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Alan D. Workman
2   Harvard Medical School, Boston, Massachusetts, United States
,
Edward C. Kuan
3   University of California, Irvine, Irvine, California, United States
,
Charles C. L. Tong
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Michael A. Kohanski
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Bert W. O'malley
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Nithin D. Adappa
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
James N. Palmer
1   University of Pennsylvania, Philadelphia, Pennsylvania, United States
› Author Affiliations
Further Information

Publication History

Publication Date:
06 February 2019 (online)

 
 

    Objective: Patients undergoing endoscopic resection of sinonasal neoplasms with skull base involvement can develop chronic rhinosinusitis after treatment, and may occasionally benefit from additional endoscopic sinus surgery (ESS). We investigate the incidence of revision surgery, risk factors, and outcomes associated with revision ESS after endoscopic skull base surgery (SBS) for sinonasal neoplasms.

    Study Design: Retrospective chart review.

    Setting: Tertiary care university hospital.

    Participants: Patients with sinonasal neoplasms with skull base involvement who underwent endoscopic resection at a single institution from 2004 through 2017.

    Main Outcome Measures: Incidence and timing of revision surgery, Lund-Mackay (LM) scores, and Sino-Nasal Outcome Test (SNOT-22) scores.

    Results: Eighty-five patients with complete data were included, with a mean age of 55 years. Sixty-seven percent of neoplasms were malignant. Fifty-five percent of patients required intradural dissection as part of their resection. Fifty-three percent of patients received radiation as part of their oncologic therapy, and 28% received chemotherapy. Revision ESS was indicated in 18 (21%) cases, 12 (14%) of which were due to chronic rhinosinusitis (CRS). Time between initial resection and revision ESS was an average of 45 months (range, 7–144 months). Pre- and post-SBS LM scores were not significantly different (5.7 vs. 4.6, p = 0.438), although pre- and post-SBS SNOT-22 scores showed significant improvement (29.5 vs. 24.2, p = 0.047). There was a trend to improvement, although not statistically significant, between SNOT-22 scores after initial SBS and after revision ESS (24.2 vs. 19.9, p = 0.129). Malignant pathology correlated with need for revision ESS (OR 5.07, 95% confidence interval: 1.08–23.90, p = 0.04).

    Conclusion: A significant proportion of patients may develop clinically significant sinusitis and benefit from revision ESS after endoscopic skull base surgery for sinonasal neoplasms, with intervention occurring, on average, just under 4 years after initial tumor resection. Malignant pathology correlated with need for revision ESS.


    #

    No conflict of interest has been declared by the author(s).